Cargando…

Valuation techniques : discounted cash flow, earnings quality, measures of value added, and real options /

Analysis and insights from top thought leaders on a pivotal topic in investing and asset management Valuation is the cornerstone for investment analysis, and a thorough understanding and correct application of valuation methodologies are critical for long-term investing success. Edited by two leadin...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Larrabee, David T.
Otros Autores: Voss, Jason Apollo
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Hoboken, New Jersey : John Wiley & Sons, Inc., ©2013.
Colección:CFA Institute investment perspectives series.
Temas:
Acceso en línea:Texto completo
Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocn795645162
003 OCoLC
005 20240329122006.0
006 m o d
007 cr un|---uuuuu
008 120614s2013 nju ob 001 0 eng
010 |a  2012024652 
040 |a DLC  |b eng  |e pn  |c DLC  |d YDX  |d N$T  |d EBLCP  |d YDXCP  |d E7B  |d CDX  |d IDEBK  |d B24X7  |d UMI  |d DEBSZ  |d RECBK  |d OCLCF  |d DEBBG  |d OCLCQ  |d AZK  |d LOA  |d COCUF  |d Z5A  |d MOR  |d PIFAG  |d ZCU  |d OCLCQ  |d MERUC  |d OCLCQ  |d K6U  |d OCLCQ  |d U3W  |d STF  |d WRM  |d NRAMU  |d ICG  |d INT  |d VT2  |d OCLCQ  |d WYU  |d TKN  |d UAB  |d DKC  |d AU@  |d OCLCQ  |d UKCRE  |d BOL  |d UKAHL  |d AAA  |d OCLCO  |d OCLCQ  |d TOH  |d OCLCQ  |d OCLCO  |d EZC  |d UWO 
019 |a 852499655  |a 865012450  |a 961567671  |a 962678273  |a 966109441  |a 988434791  |a 991957971  |a 1034892155  |a 1037797871  |a 1038604628  |a 1045544884  |a 1114470632  |a 1148072823  |a 1153486052  |a 1294536955 
020 |a 9781118417607  |q (epub) 
020 |a 1118417607  |q (epub) 
020 |a 9781118421796  |q (pdf) 
020 |a 1118421795  |q (pdf) 
020 |a 9781118450178  |q (mobipocket) 
020 |a 1118450175  |q (mobipocket) 
020 |a 1118397436 
020 |a 9781118397435 
020 |z 9781118397435  |q (cloth) 
020 |a 9781283700252  |q (MyiLibrary) 
020 |a 1283700255 
028 0 1 |a EB00066832  |b Recorded Books 
029 1 |a AU@  |b 000049549028 
029 1 |a CHNEW  |b 000601813 
029 1 |a CHVBK  |b 303056770 
029 1 |a DEBBG  |b BV040784443 
029 1 |a DEBBG  |b BV041051725 
029 1 |a DEBBG  |b BV041909759 
029 1 |a DEBBG  |b BV044188493 
029 1 |a DEBSZ  |b 39731101X 
029 1 |a DEBSZ  |b 449303179 
029 1 |a GBVCP  |b 738855006 
029 1 |a NZ1  |b 14838467 
035 |a (OCoLC)795645162  |z (OCoLC)852499655  |z (OCoLC)865012450  |z (OCoLC)961567671  |z (OCoLC)962678273  |z (OCoLC)966109441  |z (OCoLC)988434791  |z (OCoLC)991957971  |z (OCoLC)1034892155  |z (OCoLC)1037797871  |z (OCoLC)1038604628  |z (OCoLC)1045544884  |z (OCoLC)1114470632  |z (OCoLC)1148072823  |z (OCoLC)1153486052  |z (OCoLC)1294536955 
037 |a CL0500000237  |b Safari Books Online 
042 |a pcc 
050 0 0 |a HG4028.V3 
072 7 |a BUS  |x 036060  |2 bisacsh 
082 0 0 |a 332.63/221  |2 23 
049 |a UAMI 
100 1 |a Larrabee, David T. 
245 1 0 |a Valuation techniques :  |b discounted cash flow, earnings quality, measures of value added, and real options /  |c David T. Larrabee and Jason A. Voss. 
260 |a Hoboken, New Jersey :  |b John Wiley & Sons, Inc.,  |c ©2013. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
340 |g polychrome.  |2 rdacc  |0 http://rdaregistry.info/termList/RDAColourContent/1003 
347 |a data file 
490 1 |a CFA Institute investment perspectives 
500 |a Includes index. 
588 0 |a Print version record and CIP data provided by publisher. 
504 |a Includes bibliographical references and index. 
520 |a Analysis and insights from top thought leaders on a pivotal topic in investing and asset management Valuation is the cornerstone for investment analysis, and a thorough understanding and correct application of valuation methodologies are critical for long-term investing success. Edited by two leading valuation experts from CFA Institute, this book brings together the insights and expertise of some of the most astute and successful investment minds of the past 50 years. From Benjamin Graham, the "father of value investing," to Aswath Damodaran, you'll learn what these investment luminaries have to say about investment valuation techniques, including earnings and cash flow analysis.-Features the best thinking on valuation from the industry's masters on the topic, supplemented with dozens of fascinating and instructive real-world examples -Comprehensively discusses special valuation situations, such as real options, employee stock options, highly leveraged firms, corporate takeovers, and more -Supplies you with the tools you need to successfully navigate and thrive in the ever-changing financial markets -Is being produced with the full support and input of CFA Institute, the world's leading association of investment professionals 
505 0 0 |t Foreword --  |t Introduction --  |g Part I.  |t : Valuation Perspectives: Then and Now --  |g 1.  |t : Two Illustrative Approaches to Formula Valuations of Common Stocks --  |t Notes --  |g 2.  |t : Seeking a Margin of Safety and Valuation --  |t Two Basic Investment Goals --  |t The Price of Money is Fake --  |t The Future is Uncertain --  |t Dealing with Macro Risk --  |t Owning an Enterprise Preserves Purchasing Power --  |t Seek a Margin of Safety --  |t Valuation --  |t Business Model Erosion --  |t Focus on Assets, Not on Residual Equity. 
505 0 0 |t ManagementFlexibility to Look Different --  |t Conclusion --  |t Question and Answer Session --  |t Note --  |g Part II.  |t : Valuation Methodologies --  |g 3.  |t : Company Performance and Measures of Value Added --  |t Foreword --  |t Introduction --  |t How Value Is Created --  |t Relating New Performance Methods to Capital-Budgeting Techniques --  |t Summary --  |t Traditional Measures of Performance --  |t Return-on-Investment Ratios --  |t Tobin's q --  |t Summary --  |t Measures of Value Added --  |t Economic Profit --  |t Market Value Added --  |t Reconciling Economic Value Added with Market Value Added --  |t Challenges in Applying Value-Added Measures --  |t Holt's Cfroi --  |t Summary. 
505 0 0 |t Comparison of Alternative Performance MeasuresThe Sample --  |t The Variables --  |t Empirical Results --  |t Summary --  |t Conclusions --  |g Appendix 3.  |t A: The Firm's Cost Of Capital --  |t Cost of Debt --  |t Cost of Preferred Stock --  |t The Cost of Common Equity --  |t Weighted-Average Cost of Capital --  |t Issues in Calculating a WACC --  |g Appendix 3.  |t B: Net Present Value and Internal Rate of Return --  |t Notes --  |g 4.  |t : The Affordable Dividend Approach to Equity Valuation --  |t Affordable Dividends --  |t Affordable vs. Conventional dividends --  |t Significance of Difference --  |t Book Value vs. Economic Value weights --  |t Conclusion --  |t Notes. 
505 0 0 |g 5.  |t : Discounted-Cash-Flow Approach to ValuationThe DCF Formula --  |t Estimation of Cash Flows --  |t Discount Rate --  |t Definition --  |t External Factors --  |t Internal Factors --  |t Components --  |t Terminal Value --  |t Conclusion --  |t Question and Answer Section --  |t Note --  |g 6.  |t : Equity Securities Analysis Case Study: Merck & Company --  |t Recent Annual Reports --  |t Strategic Objectives --  |t Structural Reorganization --  |t Position on Health Care Reform --  |t Outlook for the Future --  |t Fundamentals of the U.S. Pharmaceutical Industry --  |t Pricing and the Demand for Pharmaceuticals --  |t Consolidation and Joint Ventures --  |t Marketing Trends. 
505 0 0 |t International CompetitionThe U.S. Political/Regulatory Environment --  |t Tasks to be Completed --  |g Appendix 6.  |t A: Merck & Company Financial Data --  |g Appendix 6.  |t B: Statistical Data: Pharmaceutical Industry --  |g Appendix 6.  |t C: Competitive Strategy Analysis Framework --  |g Appendix 6.  |t D: Review of the Dupont Financial Ratio Analysis Method --  |g Appendix 6.  |t E: Selected Valuation Methods --  |t Single-Stage Constant-Growth DCF Model --  |t Multistage DCF Model --  |t H-Model --  |t Financial Ratios Approaches --  |t Guideline Answers: The Merck Case --  |t The Current Issues Involved in Marketing Pharmaceuticals. 
505 0 0 |t The Competitive Structure of the U.S. Pharmaceutical Industry. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
590 |a O'Reilly  |b O'Reilly Online Learning: Academic/Public Library Edition 
650 0 |a Corporations  |x Valuation. 
650 0 |a Investment analysis. 
650 6 |a Sociétés  |x Évaluation. 
650 6 |a Analyse financière. 
650 7 |a BUSINESS & ECONOMICS  |x Investments & Securities  |x Stocks.  |2 bisacsh 
650 7 |a Corporations  |x Valuation  |2 fast 
650 7 |a Investment analysis  |2 fast 
655 7 |a dissertations.  |2 aat 
655 7 |a Academic theses  |2 fast 
655 7 |a Academic theses.  |2 lcgft 
655 7 |a Thèses et écrits académiques.  |2 rvmgf 
700 1 |a Voss, Jason Apollo. 
776 0 8 |i Print version:  |a Larrabee, David T.  |t Valuation techniques.  |d Hoboken, N.J. : John Wiley & Sons, ©2013  |z 9781118397435  |w (DLC) 2012022595 
830 0 |a CFA Institute investment perspectives series. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=918230  |z Texto completo 
856 4 0 |u https://learning.oreilly.com/library/view/~/9781118417607/?ar  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH24411811 
938 |a Books 24x7  |b B247  |n bkf00051286 
938 |a Coutts Information Services  |b COUT  |n 24081488 
938 |a EBL - Ebook Library  |b EBLB  |n EBL918230 
938 |a ebrary  |b EBRY  |n ebr10613139 
938 |a EBSCOhost  |b EBSC  |n 493539 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n cis24081488 
938 |a Recorded Books, LLC  |b RECE  |n rbeEB00066832 
938 |a YBP Library Services  |b YANK  |n 9827591 
994 |a 92  |b IZTAP